Agata Rembielak

accessibility text


Agata Rembielak

Job title

Consultant in Clinical Oncology at The Christie, Honorary Senior Clinical Lecturer at The University of Manchester

Email Address


Phone number

The Christie main site: 0 161 446 8583, The Christie at Oldham: 0161 446 7705/6


BSc (Med Phys), MD (Med), PhD (Med), MA (Clin Ed),MRCR


Palliative radiotherapy, Skin

Started at The Christie (Year)



  • Treating patients with skin cancer by the means of radiotherapy (superficial, electron, photon and brachytherapy)
  • Treating patients with palliative radiotherapy (not site specific)
  • Clinical lead for skin cancer (non-surgical treatment) and for palliative radiotherapy
  • Member of Drug and Therapeutic Committee
  • Member of Greater Manchester Cancer Skin Pathway Board

Professional biography

Dr Agata Rembielak is a highly experienced Clinical Oncology Consultant with an excellent knowledge of advanced radiation technology and brachytherapy.

She graduated from medicine and medical physics in Poland. She then enrolled in specialist training in radiation oncology and clinical-research fellowships which she undertook in Poland, Australia and Canada. She holds a PhD in medical sciences. In 2007 she joined The Christie Hospital as a clinical research fellow, leading to a MD qualification from the University of Manchester. She now holds a substantive consultant post at The Christie. In 2017 she was appointed Honorary Senior Lecturer at The University of Manchester. At The Christie at Oldham she set up and successfully runs the Rapid Access Palliative Radiotherapy Clinic.

At a national level Dr Rembielak has been a faculty for The Royal College of Radiologists (RCR) Skin Cancer Day and has organised and lectured at RCR Palliative Radiotherapy Day. She leads on RCR e-learning in skin cancer and on RCR consent project in radiotherapy (skin cancer and benign skin conditions). She represents RCR and The Christie at the British Association of Dermatologist (co-author of skin SCC guidelines), the National Institute for Health and Care Excellence (NICE), the NHS England Cancer Programme Skin Timed Pathway Task and Finish Group and The Skin Cancer Surgery James Lynd Alliance Priority Setting Partnership). She collaborates very closely with Macmillan Cancer Support in the area of skin cancer and palliative and supportive management in cancer patients.

At an international level Dr Rembielak is a very active and respected member of the European Society for Radiotherapy and Oncology (ESTRO). She is a course director at the ESTRO live course entitled “Multidisciplinary management of non-melanoma skin cancer”. Dr Rembielak has been appointed to the Scientific Committee for the World Congress of Brachytherapy in 2021, NCRI Conferences 2020-2021 and ESTRO Conferences in 2020-2023. She chairs SIOG (International Society of Geriatric Oncology) Taskforce on adult patients with non-melanoma skin cancer and is a member of the European Organisation for Research and Treatment (EORTC) Quality of Life (QoL) Group. She is an assistant editor at the Clinical Oncology journal and co-editor at Journal of Contemporary Brachytherapy. She acts as a reviewer for many national and international scientific journals.

She has been recognized internationally and has been an invited speaker at many national and international conferences and workshops.

Research Interest

Dr Rembielak’s research interest includes non-melanoma skin cancer, particularly the role of radiotherapy and brachytherapy in skin cancer management, palliative radiotherapy and geriatric oncology. At a national level Dr Rembielak is a member of Skin Cancer Group at The National Cancer Research Institute (NCRI) and leads radiation oncology studies within the group. Currently she is CI for an NCRI clinical trial looking at postoperative radiotherapy in high risk cutaneous SCC. At an international level she is a member of GEC-ESTRO H&N and Skin Working Group (Secretary and Skin Cancer Lead) and co-author of the ESTRO skin brachytherapy guidelines.

Her other research interests include technical radiotherapy and systemic treatments in concurrent and sequential settings with radiotherapy.

Her research and clinical activity have led to an impressive record of papers in peer-reviewed scientific journals, book chapters and presentations

Educational Interests

Dr Rembielak is recognised as a knowledgeable and respected medical educator and has been involved in teaching across many staff groups. She holds an MA degree in Clinical Education from Edge Hill University, UK. She acts as an examiner at The Christie FRCR Part 2 exam course. Her expertise and enthusiasm manifest in considerable contribution to education and training in radiation and clinical oncology at a regional, national and international level. She also regularly contributes to teaching in dermatology, radiography, surgical and plastic oncology.